Deleware Testosterone Heart Attack & Stroke Lawsuits – Current AndroGel Lawsuit Information for Residents of Deleware
Deleware men who suffered one or more cardiovascular incidents including heart attack and stroke while taking testosterone may have legal grounds to file a Deleware AndroGel lawsuit. This page provides a background for the claims made by testosterone lawsuits and who is eligible to file an AndroGel stroke or heart attack lawsuit in Deleware.
Deleware AndroGel Lawsuits
If you or a family member suffered a heart attack, stroke, or another cardiac event while taking supplemental testosterone in Deleware, you may have legal grounds for filing a Deleware Androgel lawsuit. Filing a testosterone lawsuit in Deleware serves two purposes:
First, a Deleware Androgel lawsuit can achieve financial compensation for your family for the suffering, damages, and medical expenses encountered because of a heart attack or stroke from testosterone therapy. Survivors of stroke and heart attack may face medical complications far into the future or even for the rest of their lives.
Second, an onslaught of testosterone lawsuits may be the best course of action for patients harmed by the substance who wish to exert pressure on AbbVie and other producers to be accountable to consumer safety. Deleware testosterone lawsuits and Androgel heart attack or stroke claims may join forces with other from around the country in a Multi-District Litigation (MDL), bringing individual consumers together to pursue justice and safeguard others against the same dangers in the future.
Our attorneys handle Androgel lawsuits for heart attack and stroke in Deleware and throughout the United States, and offer no-cost, no-obligation Deleware testosterone lawsuit case review for persons who suffered from a heart attack or stroke while having hormone replacement therapy. To consult with and ask questions of a Deleware testosterone attorney and to learn about AndroGel lawsuit time limits in Deleware, please complete our online contact form. One of our attorneys handling Deleware stroke and heart attack testosterone lawsuits will contact you promptly.
About Testosterone Lawsuits for Stroke and Heart Attack
The first AndroGel lawsuits -- two testosterone stroke lawsuits and four testosterone heart attack lawsuits -- were filed in early 2014 against AbbVie, alleging the company failed to adequately warn consumers of the known cardiovascular risks associated with the therapy. These lawsuits were filed only days after the FDA issued a Safety Communication which warned of testosterone stroke and heart attack based on two recent studies. The studies found that taking supplemental testosterone increased the risk of stroke and heart attack by two- to three-fold for some demographics of men. Aimed at attracting aging men, critics say that marketing for the drug only briefly mentions the known risks of heart attack and stroke, but emphasizes claims that hormone replacement therapy can boost libido, increase muscle mass, improve physical fitness, and provide energy. Testosterone drugs have not been approved for these uses in the United States, and experts say evidence to support these claims is lacking.
AbbVie’s parent company, Abbott, has a record of lawsuits for its marketing practices in the past. In 2012, Abbott paid a settlement for $1.6 billion to the Justice Department and 45 states for illegal marketing of its epilepsy drug Depakote. A class action lawsuit related to off label marketing for Depakote surfaced in 2013. For its failure to warn the public about risks associated with its most popular drug, Humira, Abbott was issued an FDA warning in 2008. The company took nearly two years to follow the FDA’s directive to warn clinicians of Humira’s risks. The company has also been embroiled in an ongoing anti-trust lawsuit related to AndroGel and the rights for generic versions of the product.
Deleware Testosterone Lawsuits Are Not Class Action Lawsuits
Many persons who have suffered from stroke or heart attack wonder if filing a Deleware AndroGel lawsuit could yield meaningful compensation for themselves or their family. Deleware testosterone lawsuits are not class action lawsuits, in which each plaintiff can expect to receive only a small, symbolic settlement. Deleware AndroGel and other testosterone lawsuits will likely join forces into a Multi-District Litigation (MDL), in which each case will be considered on its own merit and each plaintiff will receive compensation based on the particulars of their situation and degree of suffering.
Our firm represents all persons involved in a Deleware testosterone lawsuit for heart attack or stroke on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation, complete our brief online contact form. One of our Deleware AndroGel lawyers will contact you shortly to answer your questions as definitely as possible.
No-Cost, No-Obligation Deleware AndroGel Lawsuit Case Review for Persons or Families of Persons Who Suffered Stroke or Heart Attack while Taking Testosterone in Deleware
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. We have represented clients throughout the United States in complex pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and if you or a loved one has suffered from stroke or heart attack after using AndroGel or a similar product we will discuss your situation and answer as many of your questions as possible without any fee or further obligation. Should you wish our firm to represent you in an AndroGel stroke lawsuit or testosterone heart attack lawsuit in Deleware, we never charge a fee unless we are able to collect for you.